These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35266409)

  • 1. Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial.
    Jowett S; Kodabuckus S; Ford GA; Hobbs FDR; Lown M; Mant J; Payne R; McManus RJ; Sheppard JP;
    Hypertension; 2022 May; 79(5):1122-1131. PubMed ID: 35266409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial.
    Sheppard JP; Burt J; Lown M; Temple E; Lowe R; Fraser R; Allen J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Kodabuckus S; Little P; Mant J; Mollison J; Payne RA; Williams M; Yu LM; McManus RJ;
    JAMA; 2020 May; 323(20):2039-2051. PubMed ID: 32453368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
    Gu D; He J; Coxson PG; Rasmussen PW; Huang C; Thanataveerat A; Tzong KY; Xiong J; Wang M; Zhao D; Goldman L; Moran AE
    PLoS Med; 2015 Aug; 12(8):e1001860. PubMed ID: 26241895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial.
    Sheppard JP; Temple E; Wang A; Smith A; Pollock S; Ford GA; Hobbs FDR; Kenealy N; Little P; Lown M; de Lusignan S; Mant J; McCartney D; Payne RA; Williams M; Yu LM; McManus RJ;
    Lancet Healthy Longev; 2024 Aug; 5(8):e563-e573. PubMed ID: 39094592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Pharmacist-Led Deprescribing of NSAIDs in Community-Dwelling Older Adults.
    Sanyal C; Turner JP; Martin P; Tannenbaum C
    J Am Geriatr Soc; 2020 May; 68(5):1090-1097. PubMed ID: 32105355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Evaluation of Sedative Deprescribing in Older Adults by Community Pharmacists.
    Turner JP; Sanyal C; Martin P; Tannenbaum C
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1061-1067. PubMed ID: 32761069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment.
    Kaplan RI; De Moraes CG; Cioffi GA; Al-Aswad LA; Blumberg DM
    JAMA Ophthalmol; 2015 May; 133(5):560-7. PubMed ID: 25741886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
    Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
    PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial.
    Sheppard JP; Burt J; Lown M; Temple E; Benson J; Ford GA; Heneghan C; Hobbs FDR; Jowett S; Little P; Mant J; Mollison J; Nickless A; Ogburn E; Payne R; Williams M; Yu LM; McManus RJ
    BMJ Open; 2018 Oct; 8(9):e022930. PubMed ID: 30287610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis.
    Kaambwa B; Bryan S; Jowett S; Mant J; Bray EP; Hobbs FD; Holder R; Jones MI; Little P; Williams B; McManus RJ
    Eur J Prev Cardiol; 2014 Dec; 21(12):1517-30. PubMed ID: 23990660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR).
    Penaloza-Ramos MC; Jowett S; Mant J; Schwartz C; Bray EP; Sayeed Haque M; Richard Hobbs FD; Little P; Bryan S; Williams B; McManus RJ
    Eur J Prev Cardiol; 2016 Jun; 23(9):902-12. PubMed ID: 26603745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Telemonitoring and Self-Monitoring of Blood Pressure for Antihypertensive Titration in Primary Care (TASMINH4).
    Monahan M; Jowett S; Nickless A; Franssen M; Grant S; Greenfield S; Hobbs FDR; Hodgkinson J; Mant J; McManus RJ
    Hypertension; 2019 Jun; 73(6):1231-1239. PubMed ID: 31067190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Antihypertensive Therapy in Patients Older Than 80 Years: Cohort Study and Markov Model.
    Hazra NC; Rudisill C; Jackson SH; Gulliford MC
    Value Health; 2019 Dec; 22(12):1362-1369. PubMed ID: 31806192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control.
    Bress AP; Bellows BK; King JB; Hess R; Beddhu S; Zhang Z; Berlowitz DR; Conroy MB; Fine L; Oparil S; Morisky DE; Kazis LE; Ruiz-Negrón N; Powell J; Tamariz L; Whittle J; Wright JT; Supiano MA; Cheung AK; Weintraub WS; Moran AE;
    N Engl J Med; 2017 Aug; 377(8):745-755. PubMed ID: 28834469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension.
    Liao CT; Toh HS; Sun L; Yang CT; Hu A; Wei D; Melgarejo J; Zhang ZY
    JAMA Netw Open; 2023 Feb; 6(2):e230708. PubMed ID: 36848091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
    Bryant KB; Moran AE; Kazi DS; Zhang Y; Penko J; Ruiz-Negrón N; Coxson P; Blyler CA; Lynch K; Cohen LP; Tajeu GS; Fontil V; Moy NB; Ebinger JE; Rader F; Bibbins-Domingo K; Bellows BK
    Circulation; 2021 Jun; 143(24):2384-2394. PubMed ID: 33855861
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.